Page 200 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

APPENDICES
Maksymowych WP, Boire G, van SD, Wichuk S, Turk S, Boers M, Siminovitch KA, Bykerk V, Keystone E, Tak PP, van Kuijk AW, Landewé R, van der Heijde D, Murphy M, Marotta A. 14-3-3eta Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.J Rheumatol 2015 Sep;42(9):1587-94.
Plasencia C, Kneepkens EL, Wolbink G, Krieckaert CL, Turk S, Navarro-Compan V, L’Ami M, Nurmohamed MT, van der Horst-Bruinsma I, Jurado T, Diego C, Bonilla G, Villalba A, Peiteado D, Nuno L, van der Kleij D, Rispens T, Martin-Mola E, Balsa A, Pascual-Salcedo D. Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity. J Rheumatol 2015 Sep;42:1638-46.
van Beers-Tas MH, Turk SA, van Schaardenburg D. How does established rheumatoid ar- thritis develop, and are there possibilities for prevention? Best Pract Res Clin Rheumatol 2015 Aug;29:527-42.
Turk SA, van Beers-Tas MH, van Schaardenburg D.Prediction of future rheumatoid arthri- tis. Rheum Dis Clin North Am 2014 Nov;40:753-70.
R. Agca, S. Turk, D. Jansen, F. Turkstra, M. Gerritsen, M.T. Nurmohamed.Statine stoppen bij start colchicine? NTvR 2014 June;17:6-13.
Submitted for publication
Rasch LA, Turk SA, Boers M, Lems WF, van Schaardenburg D, van Tuyl LHD. Do patients with rheumatoid arthritis in remission feel normal again?
198